DARUNAVIR
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | DARUNAVIR |
| DrugBank ID | DB01264 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 17 |
| DL Predictions (≥0.7) | 39 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| atopic eczema | TxGNN Knowledge Graph | L5 |
| dermatitis, atopic | TxGNN Knowledge Graph | L5 |
| overactive bladder (disease) | TxGNN Knowledge Graph | L5 |
| rheumatoid arthritis | TxGNN Knowledge Graph | L5 |
| multidrug-resistant tuberculosis | TxGNN Knowledge Graph | L5 |
| cystic fibrosis | TxGNN Knowledge Graph | L5 |
| urticaria (disease) | TxGNN Knowledge Graph | L5 |
| allergic rhinitis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11